Titlebook: Sphingolipid Metabolism and Metabolic Disease; Xian-Cheng Jiang Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive

Migratory

外露

jungle

挣扎

Induction

Xian-Cheng JiangIntroduces the impacts of sphingomyelin synthase on metabolic disease.Presents the impact of sphingolipid metabolism on lung disease and cancers.Covers sphingolipid metabolism and drug development

zonules

Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/s/image/874248.jpg

Offstage

https://doi.org/10.1007/978-981-19-0394-6Sphingolipid biochemistry; Lipoprotein-sphingolipid; Sphingolipid-related diseases; Sphingolipid biosyn

Nmda-Receptor

0065-2598 r studies on metabolic diseases, as well as pharmaceutical research on drug discovery based on sphingolipid de novo synthase.978-981-19-0396-0978-981-19-0394-6Series ISSN 0065-2598 Series E-ISSN 2214-8019

转换

scotoma

Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases, active enzyme. Depending on the stoichiometry of the SPTLC2 and SPTLC3 subunits, the spectrum of SPT products varies. While SPTLC1 and SPTLC2 primarily form C. and C. LCBs, the combination of SPTLC1 and SPTLC3 produces a broader spectrum of LCBs. Genetic and population based studies have shown that